| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |